# S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer

> **NCT00580359** · PHASE2 · UNKNOWN · sponsor: **National Cancer Center, Korea** · enrollment: 96 (estimated)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** S-1, capecitabine

## Key facts

- **NCT ID:** NCT00580359
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-05
- **Primary completion:** 2009-12
- **Final completion:** 2010-06
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2008-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00580359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00580359, "S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00580359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*